Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation

Daily Values

Growth Metrics

Others

Bausch & Lomb (BLCO) Other financing activities (2023 - 2025)

Bausch & Lomb's Other financing activities history spans 2 years, with the latest figure at -$10.0 million for Q3 2025.

For Q3 2025, Other financing activities changed N/A year-over-year to -$10.0 million; the TTM value through Dec 2025 reached -$10.0 million, down 162.5%, while the annual FY2023 figure was $16.0 million, 433.33% up from the prior year.
Other financing activities reached -$10.0 million in Q3 2025 per BLCO's latest filing, down from $16.0 million in the prior quarter.
In the past five years, Other financing activities ranged from a high of $16.0 million in Q3 2023 to a low of -$10.0 million in Q3 2025.